Related Experiment Video
Updated: May 12, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Role of Continuous Positive Airway Pressure in the Prevention of Cardiovascular Events in Patients With Obstructive
Saif Almuzainy1, Mohamed Lemine1, Rayan Aljubeh1
1College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Background:
Obstructive sleep apnea (OSA) is prevalent among patients with cardiovascular disease and is associated with increased risk of major adverse cardiovascular events (MACE). Continuous positive airway pressure (CPAP) is the standard treatment for OSA, but its impact on cardiovascular outcomes remains uncertain, particularly in randomized controlled trials (RCTs).
Objectives:
To evaluate the effect of CPAP therapy on cardiovascular outcomes in patients with OSA, and to explore the influence of adherence on treatment efficacy.
Methods:
We conducted a systematic review and meta-analysis of RCTs comparing CPAP with placebo or usual care in adults with OSA. Databases including PubMed, Scopus, Ovid, and CINAHL were searched from inception to December 2024. Primary outcome was MACE; secondary outcomes included cardiovascular mortality, all-cause mortality, myocardial infarction, stroke, angina, heart failure, and new-onset atrial fibrillation. Subgroup analyses were performed based on CPAP adherence (≥4 hours/night vs <4 hours/night). Risk ratios (RRs) with 95 % confidence intervals (CIs) were pooled using fixed-effects model.
Results:
Eleven RCTs comprising 6139 participants were included. Overall, CPAP did not significantly reduce MACE (RR = 1.00; 95 % CI: 0.87-1.14) or secondary cardiovascular outcomes. However, in patients adherent to CPAP (≥4 hours/night), MACE was significantly reduced (RR = 0.71; 95 % CI: 0.52-0.97), and cardiovascular mortality decreased (RR = 0.36; 95 % CI: 0.14-0.91). Subgroup analyses revealed no significant benefits in non-adherent patients. Heterogeneity was low for most outcomes.
Conclusion:
CPAP therapy does not significantly reduce overall cardiovascular risk in OSA patients, except among adherent individuals. These findings underscore adherence as a critical determinant of CPAP's cardiovascular efficacy. Future trials should prioritize strategies to optimize adherence to fully evaluate CPAP's cardioprotective potential.
More Related Videos
04:53Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Published on: October 18, 2024
07:15Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation
Published on: December 5, 2025
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
Cardiopulmonary Resuscitation II: ACLS Airway Management
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Physiological Control of Respiration
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...